Literature DB >> 18027020

Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer.

Marcella Arru1, Luca Aldrighetti, Renato Castoldi, Saverio Di Palo, Elena Orsenigo, Marco Stella, Carlo Pulitanò, Francesca Gavazzi, Gianfranco Ferla, Valerio Di Carlo, Carlo Staudacher.   

Abstract

BACKGROUND: The aim of this study was to analyze the prognostic factors associated with long-term outcome after liver resection for colorectal metastases. The retrospective analysis included 297 liver resections for colorectal metastases.
METHODS: The variables considered included disease stage, differentiation grade, site and nodal metastasis of the primary tumor, number and diameter of the lesions, time from primary cancer to metastasis, preoperative carcinoembryonic antigen (CEA) level, adjuvant chemotherapy, type of resection, intraoperative ultrasonography and portal clamping use, blood loss, transfusions, complications, hospitalization, surgical margins status, and a clinical risk score (MSKCC-CRS).
RESULTS: The univariate analysis revealed a significant difference (p < 0.05) in overall 5-year survival rates depending on the differentiation grade, preoperative CEA >5 and >200 ng/ml, diameter of the lesion >5 cm, time from primary tumor to metastases >12 months, MSKCC-CRS >2. The multivariate analysis showed three independent negative prognostic factors: G3 or G4 grade, CEA >5 ng/ml, and high MSKCC-CRS.
CONCLUSIONS: No single prognostic factor proved to be associated with a sufficiently disappointing outcome to exclude patients from liver resection. However, in the presence of some prognostic factors (G3-G4 differentiation, preoperative CEA >5 ng/ml, high MSKCC-CRS), enrollment of patients in trials exploring new adjuvant treatments is suggested to improve the outcome after surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18027020     DOI: 10.1007/s00268-007-9285-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  43 in total

1.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

Review 2.  Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis.

Authors:  Henrik Petrowsky; Mithat Gonen; William Jarnagin; Matthias Lorenz; Ronald DeMatteo; Stefan Heinrich; Albrecht Encke; Leslie Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

4.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

5.  Determinants of survival following hepatic resection for metastatic colorectal cancer.

Authors:  E A Bakalakos; J A Kim; D C Young; E W Martin
Journal:  World J Surg       Date:  1998-04       Impact factor: 3.352

6.  Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes.

Authors:  Eduardo de Santibañes; Fernando Bonadeo Lassalle; Lucas McCormack; Juan Pekolj; Guillermo Ojea Quintana; Carlos Vaccaro; Mario Benati
Journal:  J Am Coll Surg       Date:  2002-08       Impact factor: 6.113

7.  Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.

Authors:  D Elias; J-F Ouellet; N Bellon; J-P Pignon; M Pocard; P Lasser
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

8.  Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Matteo Cescon; Andrea Gardini; Giovanni Varotti; Massimo Del Gaudio; Bruno Nardo; Antonino Cavallari
Journal:  Arch Surg       Date:  2002-10

Review 9.  Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.

Authors:  Masayoshi Inoue; Mitsunori Ohta; Keiji Iuchi; Akihide Matsumura; Kan Ideguchi; Tsutomu Yasumitsu; Katsuhiro Nakagawa; Kenjiro Fukuhara; Hajime Maeda; Shin-ichi Takeda; Masato Minami; Yuko Ohno; Hikaru Matsuda
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

10.  Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases.

Authors:  David A Kooby; Jennifer Stockman; Leah Ben-Porat; Mithat Gonen; William R Jarnagin; Ronald P Dematteo; Scott Tuorto; David Wuest; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

View more
  42 in total

Review 1.  Viral vector-based therapeutic cancer vaccines.

Authors:  Cecilia Larocca; Jeffrey Schlom
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

2.  Complications following liver resection for colorectal metastases do not impact on longterm outcome.

Authors:  Tony C Pang; Calista Spiro; Tim Ramacciotti; Julian Choi; Martin Drummond; Edmund Sweeney; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

Review 3.  Clinical evaluation of TRICOM vector therapeutic cancer vaccines.

Authors:  Ravi A Madan; Marijo Bilusic; Christopher Heery; Jeffrey Schlom; James L Gulley
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

4.  A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

Authors:  Michael A Morse; Donna Niedzwiecki; John L Marshall; Christopher Garrett; David Z Chang; Mebea Aklilu; Todd S Crocenzi; David J Cole; Sophie Dessureault; Amy C Hobeika; Takuya Osada; Mark Onaitis; Bryan M Clary; David Hsu; Gayathri R Devi; Anuradha Bulusu; Robert P Annechiarico; Vijaya Chadaram; Timothy M Clay; H Kim Lyerly
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

Review 5.  Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.

Authors:  Jianmin Xu; Xinyu Qin; Jianping Wang; Suzhan Zhang; Yunshi Zhong; Li Ren; Ye Wei; Shaochong Zeng; Deseng Wan; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-28       Impact factor: 4.553

6.  Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?

Authors:  Nir Lubezky; Ravit Geva; Einat Shmueli; Richard Nakache; Joseph M Klausner; Arie Figer; Menahem Ben-Haim
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

Review 7.  Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.

Authors:  Kristina Hasselgren; Per Sandström; Bergthor Björnsson
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Good candidates for a third liver resection of colorectal metastasis.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Shunji Okada; Atsuko Iwama; Yutaka Midorikawa; Masamichi Moriguchi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugutani
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

9.  Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Chizuru Matsumoto; Kenichi Matsuo; Kazuhisa Takeda; Yasuhiko Nagano; Shinji Togo
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

10.  Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status.

Authors:  D J Watkins; I Chau; D Cunningham; S S Mudan; N Karanjia; G Brown; S Ashley; A R Norman; A Gillbanks
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.